|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 327.10 CHF | +0.77% |
|
-0.67% | -0.34% |
| 07:32pm | Roche obesity drug helps patients shed 22.7% of weight in mid-stage trial | RE |
| Jun. 05 | Zealand touts promising tolerability data for obesity drug in mid-stage study | RE |
Main competitors
| Change | 5d. change | 1 months change | 3 months change | Varia. Jan 1. | 1-year change | 3-years change | 5-years change | 10-years change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| +0.55% | +2.39% | +14.42% | +15.07% | +5.28% | +47.77% | +154.68% | +460.05% | +1,406.15% | 1,009B | ||
| +2.02% | +3.30% | +3.20% | -2.86% | +12.48% | +51.48% | +47.03% | +40.25% | +102.83% | 560B | ||
| +1.02% | +4.37% | +10.25% | -2.20% | -0.55% | +21.21% | +66.03% | +102.23% | +249.58% | 401B | ||
| +2.24% | +0.41% | +3.96% | -6.20% | +0.49% | +29.51% | +17.50% | +72.04% | +243.10% | 288B | ||
| +1.85% | +0.14% | +3.91% | -5.48% | +7.65% | +22.04% | +30.54% | +45.62% | +49.34% | 272B | ||
| +4.43% | -3.11% | -0.72% | +14.16% | -12.73% | -40.46% | -47.48% | +15.49% | +53.14% | 194B | ||
| +1.15% | +3.80% | +6.07% | -4.90% | +6.80% | +21.76% | +57.55% | +47.60% | +119.60% | 189B | ||
| -0.02% | -3.92% | -3.24% | -11.01% | +5.23% | +16.93% | +66.19% | +91.55% | +49.92% | 160B | ||
| +1.36% | -0.53% | -1.55% | -2.14% | +4.58% | +12.63% | -32.63% | -33.49% | -24.94% | 148B | ||
| +1.18% | +0.16% | +0.56% | -5.71% | +6.17% | +19.71% | -13.20% | -11.81% | -21.43% | 117B | ||
| +1.15% | -0.16% | +5.30% | -3.04% | -1.44% | +0.68% | +33.61% | +112.85% | +375.55% | 113B | ||
| +1.98% | +3.53% | +5.11% | +0.28% | -5.77% | -10.90% | -18.23% | -9.44% | +7.53% | 108B | ||
| +1.89% | +3.00% | +4.36% | -6.65% | +6.22% | +28.17% | +40.23% | +14.49% | +6.26% | 103B | ||
| -0.17% | -4.28% | -8.38% | -22.34% | -8.36% | +3.03% | +92.56% | +80.76% | +505.13% | 77.57B | ||
| +1.57% | -3.75% | -5.97% | -12.52% | +1.88% | +15.26% | +9.54% | +34.15% | +6.46% | 48.56B | ||
| +0.97% | -6.20% | -12.62% | -12.36% | -20.97% | -12.62% | +1.25% | -31.64% | +226.04% | 46.02B | ||
| +1.69% | -1.01% | -4.59% | -4.28% | -2.30% | +36.81% | -30.62% | -31.33% | -59.53% | 41.02B | ||
| -0.19% | +0.35% | +0.64% | -5.45% | -23.79% | -1.61% | +57.59% | +108.14% | +331.70% | 40.46B | ||
| -0.70% | -3.20% | -4.66% | +7.69% | +9.55% | +98.20% | +374.20% | +228.75% | -36.44% | 39.81B | ||
| Average | +0.99% | -0.20% | +0.84% | -3.68% | -0.50% | +18.93% | +47.70% | +70.33% | +188.95% | 208.26B | |
| Weighted average by Cap. | +0.67% | +1.35% | +5.74% | +1.14% | +3.29% | +27.98% | +65.14% | +154.95% | +454.39% |
- Stock Market
- Equities
- ROP Stock
- ROG Stock
- Sector Roche Holding AG
Select your edition
All financial news and data tailored to specific country editions
















